Related Experiment Video
Updated: Jul 30, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Construction and integrated analysis of the ceRNA network hsa_circ_0000672/miR-516a-5p/TRAF6 and its potential
Xing Liu1,2, Mingxing Wu1, Yan He2
1Department of Cardiology, Xiangtan Central Hospital, Xiangtan, China.
Insights
Atrial fibrosis, a key factor in atrial fibrillation (AF), is linked to a specific circRNA network. Elevated hsa_circ_0000672 in AF patients may indicate fibrosis, potentially via the hsa_circ_0000672/hsa_miR-516a-5p/TRAF6 axis.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Biomedical Engineering
Background:
- Atrial fibrosis significantly contributes to the initiation and progression of atrial fibrillation (AF).
- Understanding the molecular mechanisms underlying atrial fibrosis is crucial for developing targeted therapies for AF.
- Circular RNAs (circRNAs) are emerging as key regulators in various biological processes, including cardiac remodeling.
Purpose of the Study:
- To identify a circRNA-miRNA-mRNA competitive endogenous RNA (ceRNA) regulatory network associated with atrial fibrosis in AF.
- To specifically validate the hsa_circ_0000672/hsa_miR-516a-5p/TRAF6 ceRNA axis in the context of AF-related fibrosis.
Main Methods:
- Construction of a ceRNA network using bioinformatic tools and literature review.
- Assessment of left atrium (LA) fibrosis by LA low voltage mapping.
- Quantitative real-time polymerase chain reaction (qRT-PCR) to measure gene expression in peripheral blood monocytes.
- Dual-luciferase reporter assay to confirm the interaction between circRNA, miRNA, and target gene.
Main Results:
- A ceRNA network was constructed, involving up-regulated hsa_circ_0000672 and hsa_circ_0003916, down-regulated miR-516a-5p, and up-regulated hub genes (KRAS, SMAD2, TRAF6, MAPK11, SMURF1).
- Hub genes were significantly enriched in TGF-beta and MAPK signaling pathways.
- Hsa_circ_0000672 expression was significantly higher in peripheral blood monocytes of persistent AF patients compared to controls, and even higher in those with LA low voltage (fibrosis).
- Dual-luciferase assay confirmed hsa_circ_0000672 acts as a sponge for miR-516a-5p, regulating TRAF6 expression.
Conclusions:
- Hsa_circ_0000672 expression in peripheral blood monocytes may serve as a potential biomarker for atrial fibrosis in AF.
- The identified hsa_circ_0000672/hsa_miR-516a-5p/TRAF6 axis is preliminarily validated and may play a role in atrial fibrosis pathogenesis.
- This study provides insights into the molecular mechanisms of atrial fibrosis and suggests potential therapeutic targets for AF.
Abstract:
Atrial fibrosis is a crucial contributor to initiation and perpetuation of atrial fibrillation (AF). This study aimed to identify a circRNA-miRNA-mRNA competitive endogenous RNA (ceRNA) regulatory network related to atrial fibrosis in AF, especially to validate hsa_circ_0000672/hsa_miR-516a-5p/TRAF6 ceRNA axis in AF preliminarily. The circRNA-miRNA-mRNA ceRNA network associated with AF fibrosis was constructed using bioinformatic tools and literature reviews. Left atrium (LA) low voltage was used to represent LA fibrosis by using LA voltage matrix mapping. Ten controls with sinus rhythm (SR), and 20 patients with persistent AF including 12 patients with LA low voltage and 8 patients with LA normal voltage were enrolled in this study. The ceRNA regulatory network associated with atrial fibrosis was successfully constructed, which included up-regulated hsa_circ_0000672 and hsa_circ_0003916, down-regulated miR-516a-5p and five up-regulated hub genes (KRAS, SMAD2, TRAF6, MAPK11 and SMURF1). In addition, according to the results of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, these hub genes were clustered in TGF-beta and MAPK signaling pathway. In the patients with persistent AF, hsa_circ_0000672 expression in peripheral blood monocytes was significantly higher than those in controls with SR by quantitative real-time polymerase chain reaction (p-value < 0.001). Furthermore, hsa_circ_0000672 expression was higher in peripheral blood monocytes of persistent AF patients with LA low voltage than those with LA normal voltage (p-value = 0.002). The dual-luciferase activity assay confirmed that hsa_circ_0000672 exerted biological functions as a sponge of miR-516a-5p to regulate expression of its target gene TRAF6. Hsa_circ_0000672 expression in peripheral blood monocytes may be associated with atrial fibrosis. The hsa_circ_0000672 may be involved in atrial fibrosis by indirectly regulating TRAF6 as a ceRNA by sponging miR-516a-5p.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Mechanism of Cardiac Arrhythmias
Node Analysis for AC Circuits
To unravel the complexities of this system, nodal analysis is employed, a powerful technique founded on Kirchhoff's current law (KCL), which remains valid for phasors. AC circuits can effectively be...

